Skip to main navigation

About
- Company
- Leadership
- Laboratory
- Careers
Products
Applications
Technology
Resources
- News Center
- Conferences
- Library
- Blog
- Contact
Investors

Press Releases

Press Releases

Year

Nov 30, 2022

Personalis and UCSF to Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer

Nov 21, 2022

Personalis to Present at the 34th Annual Piper Sandler Healthcare Conference

Nov 07, 2022

Personalis Presents Data from New Platform Features at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

Nov 02, 2022

Personalis Reports Third Quarter 2022 Financial Results

Oct 31, 2022

Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business

Oct 19, 2022

Personalis to Announce Third Quarter 2022 Financial Results

Oct 04, 2022

Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer

Aug 30, 2022

Personalis to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Aug 17, 2022

Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight Diagnostics

Aug 16, 2022

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pagination

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Displaying 1 - 10 of 33

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website

© 2022 Personalis Inc. All rights reserved.